AI steps in to ease Chemo's toll: new trial for cancer patients

NCT ID NCT07198581

Recruiting now Symptom relief Sponsor: Incheon St.Mary's Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether an AI system can help doctors better manage chemotherapy side effects in people with breast or colorectal cancer. About 174 patients will be split into two groups: one where doctors use AI suggestions to adjust care, and one with standard care alone. The goal is to see if AI assistance can improve patients' quality of life during treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: LLM-assisted chemotherapy side effect management (behavioral intervention using AI recommendations)
What this could lead to: If successful, this could provide a new tool to help doctors better manage chemotherapy side effects, potentially improving patients' quality of life during treatment.
What could go wrong: This is an early-stage trial with only 174 participants, so results may not apply to all patients. The AI recommendations are for reference only, and the study focuses on feasibility, not a proven treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm colorectal cancer colorectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER COLORECTAL CANCER

Contacts and locations

Locations

Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea
RECRUITING

Incheon, 21431, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.